Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing - Wikidata - awgldk - TriplyDB

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

http://www.wikidata.org/entity/Q36004826

about

Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology Cell-type specific penetrating peptides: therapeutic promises and challenges Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.MiRNA inhibition in tissue engineering and regenerative medicine.MicroRNA delivery for regenerative medicine.The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness.Nanoparticle delivery of miR-223 to attenuate macrophage fusion Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5 Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids.Progress in microRNA delivery.Canonical and non-canonical barriers facing antimiR cancer therapeutics MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.microRNA therapies in cancer.MicroRNA in the Diseased Pulmonary Vasculature: Implications for the Basic Scientist and Clinician.Nanotechnology for delivery of peptide nucleic acids (PNAs)An overview of viral and nonviral delivery systems for microRNA.Engineering the RNA-Nanobio Interface.FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy.Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides.

P2860

Q26777595-38C691FC-D95C-46FD-AC3B-03577340C160 Q26800103-5F010B9A-394D-4B44-9D75-71ECB94535B6 Q26830434-44DFFA12-0D5D-4B97-84DC-44677DF08F23 Q26830537-ABB6D4E8-318A-4FEE-A8FA-E50F52FF130D Q27023295-B3C20A28-27E5-4D06-8162-554DE81CB530 Q30632163-02B710EA-D72B-4397-A8C4-0B278325AE72 Q34622662-8C34B7B8-8004-4896-AFCC-369ABD24E576 Q35799937-8840B6FB-7E25-4C93-987D-F6C52E55A0AC Q35863950-D41F204A-97FF-42A0-A4A4-9897E5DA3103 Q35966911-8BFDF615-B0EB-461A-A403-908298048367 Q36490744-DD6C9B5D-A416-46CD-8F96-EA2D5658F38C Q37045471-9FA722C3-23AE-49E4-84EB-5C084A053C21 Q37045844-0C82A901-18EB-4AD7-B52E-3ADC3E05EF49 Q37167989-3B81CA9B-3072-41FA-A65F-4D995F92DD64 Q37460152-D0CD6A6E-D74D-4658-9BA7-4F555A9C9FD0 Q37478933-C33AC8D0-1A1D-46DD-B340-6789AB232371 Q38112723-443AC44E-0D91-446B-A5C4-585DF76C7BF9 Q38267957-E03EB19C-6C44-4588-B59B-E3C2132427DC Q38294395-D2C56233-12D7-49C7-99A7-9EBE378CEED2 Q38521725-8F8ACECD-D48C-4BC3-A399-20715A77F3D4 Q38679814-7ACC9C85-CF11-4EFD-BD4F-ED5D67C929DA Q38699488-656FC652-0716-4B4A-B294-17AFEEEE7DE0 Q41038422-8A15FECE-B338-4BCF-A3FA-27B745E7B52B Q41513431-F6A537C1-0EEB-415D-911F-44CE8DA20B8B Q41557167-800349E3-94AF-47AD-B3C9-FA910E8554F1 Q47119028-EBA7014A-2F9A-4B14-8E82-D4C82CC50AA6 Q52642353-5CFAF0AA-777F-4F9A-8835-CAEEDA199F2E

P2860

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

http://www.wikidata.org/entity/Q36004826

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@ast

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@en

type

label

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@ast

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@en

prefLabel

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@ast

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@en

P1433

Q36004826-61CF5587-9DA3-48F8-B95A-15ED52EE097E

P1476

Q36004826-AE4B416E-C963-4E72-AD7C-4D848FE43B42

P2093

Q36004826-4F875390-D437-4516-917A-7ED60D27085A

Q36004826-5FA1A178-58E5-4BF1-8B85-FECEA5294D76

P2860

Q36004826-0061CDA1-622F-43E3-9683-824877453105

Q36004826-09A84DEB-3AAD-40F5-A08A-52C1F6568822

Q36004826-09EADF0C-2FDE-4ED4-B256-4189B46F0C2F

Q36004826-135E6E2C-16FA-434C-AE20-1590033AD9F4

Q36004826-143019B8-194C-4BEB-9BCF-4B4765C75408

Q36004826-1E21D766-F094-4961-809C-B80120E11CCE

Q36004826-21264ECF-B3B9-4BC3-BCB3-DD24D1FE15E6

Q36004826-2CBD7BA4-4CEF-4D47-8E07-F1646BBAEE98

Q36004826-2F8BB287-2B53-4FB9-B807-5CB185753357

Q36004826-30887753-44EE-4E1C-9DD9-3430A2CE3076

P304

Q36004826-434CE1D9-6764-4D24-9B90-CE6F925B33EB

P31

Q36004826-D5EC478F-DB2F-401D-BB7A-DD399FA5B3A9

P356

Q36004826-0DDD7AA4-576D-4AF6-A46F-44D7FAF0FD4F

P407

Q36004826-2EAE5E31-895C-4533-B882-C0DE8A66DA96

P433

Q36004826-E4FEFA46-E205-4C55-997B-41C14D4C21B5

P478

Q36004826-370F308E-39A9-44EC-B385-75F37C51CDC6

P577

Q36004826-3B694796-521C-428C-9058-5D322F299642

P5875

Q36004826-26A71E07-5C8F-458A-BA4D-9AA7A6AF7915

P698

Q36004826-53240F4F-34D5-469A-B71B-C93B627F66FD

P921

Q36004826-BD59BD79-EC94-480C-9C89-5180E6FE9657

Q36004826-CC72E386-AC25-4967-9B30-53FC13423610

P932

Q36004826-F834118B-4B6C-4103-8CEA-FA0B7C473DAD

P356

P1433

Molecular Pharmaceutics

P1476

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

@en

P2093

Christopher J Cheng

http://www.w3.org/2001/XMLSchema#string

W Mark Saltzman

http://www.w3.org/2001/XMLSchema#string

P2860

MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Efficient inhibition of miR-155 function in vivo by peptide nucleic acids

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation

Inositol phosphatase SHIP1 is a primary target of miR-155

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Silencing of microRNAs in vivo with 'antagomirs'

Achieving efficient delivery of morpholino oligos in cultured cells

Endo-Porter: a novel reagent for safe, effective delivery of substances into cells

P304

1481-1488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP300081S

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223964366

http://www.w3.org/2001/XMLSchema#string

P698

22482958

http://www.w3.org/2001/XMLSchema#string

P921

P932

3366258

http://www.w3.org/2001/XMLSchema#string